1.Role of IL-17A in acute inhalational pneumonia caused by highly virulent and multidrug-resistant Staphylococcus aureus
Qi KUANG ; Xiaoyu ZHU ; Lu LI ; Xueyan WANG ; Peijie YAN ; Lili ZHANG ; Meng LÜ ; Lingfei HU ; Dongsheng ZHOU ; Wenhui YANG
Acta Universitatis Medicinalis Anhui 2026;61(4):599-605
ObjectiveTo investigate the role of interleukin (IL)-17A in acute inhalational pneumonia induced by the highly drug-resistant and hypervirulent Staphylococcus aureus strain USA300-R in mice. MethodsAn acute inhalational pneumonia model was established in mice using an aerosolized pulmonary delivery technique. RNA sequencing (RNA-seq) and enzyme-linked immunosorbent assay (ELISA) were employed to examine the expression dynamics of Il17a mRNA and IL-17A protein, respectively, in the lungs of infected mice. Il17a knockout (Il17a-/-) mice were generated using CRISPR/Cas9 gene editing technology. The survival rate, body weight, bacterial load in lung tissue, and histopathological changes were compared between Il17a-/- and wild-type (WT) mice following inhalational infection with USA300-R. Results12 hours after USA300-R infection, compared to pre-infection, the expression level of Il17a mRNA in lung tissue and the level of IL-17A protein in bronchoalveolar lavage fluid (BALF) increased by approximately 50-fold (P<0.01) and 6-fold (P<0.001), respectively. Compared to WT mice, Il17a-/- mice exhibited approximately 10-fold higher bacterial loads in lung tissue at both 12 and 24 hours post-infection (P<0.001, P<0.05). However, they showed significantly attenuated lung histopathological injury, reduced alveolar wall thickening, markedly decreased neutrophil infiltration, and an approximately 50% improvement in survival rate (P<0.05). ConclusionIn acute Staphylococcus aureus USA300-R inhalational pneumonia, IL-17A contributes to bacterial clearance by recruiting neutrophils; however, excessive neutrophil infiltration exacerbates pulmonary inflammation and injury, reduces survival rates, and represents a potential therapeutic target.
2.Change trend of compound obesity among different occupational groups in nine provinces of China from 1993 to 2018
Lixin HAO ; Yu WU ; Liusen WANG ; Lili CHEN ; Boya ZHAO ; Zhongting LU ; Zhihong WANG ; Bing ZHANG ; Hongru JIANG ; Huijun WANG
Journal of Environmental and Occupational Medicine 2026;43(2):160-167
Background The global prevalence of obesity is on the rise and is closely associated with various chronic non-communicable diseases such as cardiovascular diseases and diabetes. There is a relative lack of long-term dynamic studies on compound obesity among occupational populations. Objective To explore the changing trends of compound obesity among different occupational groups aged 18–59 years in nine provinces (autonomous regions, municipalities) of China from 1993 to 2018, and to provide a scientific basis for formulating targeted weight management strategies for occupational populations. Methods A total of
3.Association between changes in body mass index and hypertension among different occupational groups
Zhongting LU ; Lili CHEN ; Hongru JIANG ; Lixin HAO ; Liusen WANG ; Weiyi LI ; Yu WU ; Huijun WANG ; Bing ZHANG ; Jiguo ZHANG ; Zhihong WANG
Journal of Environmental and Occupational Medicine 2026;43(2):168-173
Background With rising obesity rates and earlier hypertension onset among occupational populations, there is an urgent need to elucidate the long-term cardiovascular impacts of dynamic body weight patterns. Current evidence lacks trajectory modeling studies examining occupation-specific prevention strategies. Objective To investigate the association between long-term body mass index (BMI) trajectories and incident hypertension risk in Chinese working adults, and to examine occupation-specific heterogeneity in this relationship. Methods A dynamic sub-cohort of 4 413 occupational participants was constructed from ten survey waves (1991–2018) of the China Health and Nutrition Survey (CHNS). Eligible individuals had valid key BMI records at three or more independent follow-ups before the outcome event; the individual baseline was set as the year of their first participation in the survey. Group-based trajectory modeling (GBTM) was used to identify BMI change patterns. Cox proportional hazards regression was used to calculate hazard ratios (HRs) and 95% confidence interval (CI) for hypertension incidence across trajectory groups, with stratified analysis by occupational categories. Results Among
4.WANG Shouchuan's Experience in Treating Childhood Absence Epilepsy Based on the Theory of "Five Zang (脏) Organs Storing the Spirit"
Zhiyuan LU ; Lili LIN ; Yuhan WANG ; Qigang DAI ; Erxi CHAI ;
Journal of Traditional Chinese Medicine 2026;67(19):2053-2058
This paper summarizes professor WANG Shouchuan's clinical experience in treating childhood absence epilepsy based on the theory of "five zang (脏) organs storing the spirit". It is believed that dysfunction of the five zang organs in storing the spirit is the key pathogenesis of childhood absence epilepsy, proposing that the fundamental therapeutic principle is regulating the spirit by tonifying the five zang organs. Treatment is performed based on differentiation of heart, liver, spleen, lung, and kidney epilepsy. For heart epilepsy, the treatment focuses on harmonizing qi and blood and regulating heart spirit, with Yangxin Anshen Decoction (养心安神汤) or Daochi Ningshen Decoction (导赤宁神汤) selected according to deficiency or excess syndrome. For liver epilepsy, the treatment aims to subdue wind-yang and calm liver spirit, using Bugan Zhenhun Decoction (补肝镇魂汤) or Gouma Qianhun Decoction(钩麻潜魂汤) based on deficiency or excess syndrome. For spleen epilepsy, the treatment concentrates on resolving phlegm-turbidity and restoring spleen thought, employing Guipi Yangyi Decoction (归脾养意汤) or Changyu Huatan Decoction (菖郁化痰汤) in line with deficiency or excess syndrome. For lung epilepsy, the treatment focuses on expelling exogenous pathogens and consolidating lung corporeal soul, applying Yuping Gupo Decoction (玉屏固魄汤) or Xiebai Anpo Decoction (泻白安魄汤) according to deficiency or excess syndrome. For kidney epilepsy, the treatment aims to strengthen the primordial qi and replenish kidney will, with Dihuang Yuanzhi Decoction (地黄远志汤). The self-made Dingxian Powder (定痫散) is used dynamically throughout the course, emphasizing the flexible application of decoctions, pills and syrupsis.
5.WANG Shouchuan's Experience in Treating Childhood Absence Epilepsy Based on the Theory of "Five Zang (脏) Organs Storing the Spirit"
Zhiyuan LU ; Lili LIN ; Yuhan WANG ; Qigang DAI ; Erxi CHAI ;
Journal of Traditional Chinese Medicine 2026;67(19):2053-2058
This paper summarizes professor WANG Shouchuan's clinical experience in treating childhood absence epilepsy based on the theory of "five zang (脏) organs storing the spirit". It is believed that dysfunction of the five zang organs in storing the spirit is the key pathogenesis of childhood absence epilepsy, proposing that the fundamental therapeutic principle is regulating the spirit by tonifying the five zang organs. Treatment is performed based on differentiation of heart, liver, spleen, lung, and kidney epilepsy. For heart epilepsy, the treatment focuses on harmonizing qi and blood and regulating heart spirit, with Yangxin Anshen Decoction (养心安神汤) or Daochi Ningshen Decoction (导赤宁神汤) selected according to deficiency or excess syndrome. For liver epilepsy, the treatment aims to subdue wind-yang and calm liver spirit, using Bugan Zhenhun Decoction (补肝镇魂汤) or Gouma Qianhun Decoction(钩麻潜魂汤) based on deficiency or excess syndrome. For spleen epilepsy, the treatment concentrates on resolving phlegm-turbidity and restoring spleen thought, employing Guipi Yangyi Decoction (归脾养意汤) or Changyu Huatan Decoction (菖郁化痰汤) in line with deficiency or excess syndrome. For lung epilepsy, the treatment focuses on expelling exogenous pathogens and consolidating lung corporeal soul, applying Yuping Gupo Decoction (玉屏固魄汤) or Xiebai Anpo Decoction (泻白安魄汤) according to deficiency or excess syndrome. For kidney epilepsy, the treatment aims to strengthen the primordial qi and replenish kidney will, with Dihuang Yuanzhi Decoction (地黄远志汤). The self-made Dingxian Powder (定痫散) is used dynamically throughout the course, emphasizing the flexible application of decoctions, pills and syrupsis.
6.Risk factors for therapeutic plasma exchange-related adverse events in patients undergoing allogeneic hematopoietic stem cell transplantation
Jingyuan QIN ; Jing LONG ; Lili YUAN ; Yuemei ZHANG ; Jiali QIAO ; Xuelian YANG ; Qingxue YIN ; Juan CHEN
Chinese Journal of Blood Transfusion 2026;39(9):1254-1261
Objective: To investigate the incidence and independent risk factors of adverse events (AEs) associated with therapeutic plasma exchange (TPE) in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), and to provide evidence to support the safe use of TPE in clinical practice. Methods: This retrospective study included 167 allo-HSCT recipients who underwent a total of 385 TPE procedures between March 2022 and December 2023. Patients were divided into two groups according to the occurrence of TPE-related AEs. Baseline characteristics, plasma exchange parameters, and clinical features were collected. Univariate analysis and multivariable Firth logistic regression were performed to identify independent risk factors for AEs. Results: A total of 385 TPE procedures were performed in 167 allo-HSCT patients, and 33 patients (19.8%) experienced TPE-related AEs. Among the 33 patients who experienced AEs, allergic reactions were the most common (n=18, 54.5%), followed by blood pressure fluctuations (n=11, 33.3%) and hypocalcemia (n=4, 12.1%). Most AEs were classified as grade II (n=23, 69.7%), and no grade IV (fatal) events were observed. Univariate analysis demonstrated a significant difference in the incidence of AEs among different hematocrit (HCT) categories (<20%, 20%-30%, and>30%) (Fisher's exact test, P=0.022). Although the overall difference was statistically significant, none of the pairwise comparisons remained significant after Bonferroni correction (adjusted P>0.0167). Multivariable Firth logistic regression identified higher HCT levels, analyzed as a continuous variable (OR=1.07, 95% CI: 1.01-1.13, P=0.020), and TPE performed for cytokine release syndrome (CRS) (OR=9.21, 95% CI: 1.25-78.00, P=0.030) as potential independent risk factors for TPE-related AEs. Receiver operating characteristic (ROC) curve analysis showed that HCT had an AUC of 0.67 (95% CI: 0.57-0.77) for predicting AEs, with an optimal cutoff value of 24.5%, a sensitivity of 60.6%, and a specificity of 75.4%. Using this cutoff, the AEs rate was significantly higher in patients with HCT≥24.5% than in those with HCT<24.5% (37.7% vs 11.4%, P<0.001). Conclusion: A-mong allo-HSCT patients receiving TPE, allergic reactions were the predominant AEs. Higher HCT levels and TPE performed for CRS may be associated with an increased risk of AEs. HCT≥24.5% may help identify patients requiring intensified monitoring, although its discriminatory ability is moderate (AUC=0.67) and it should not be used as a standalone criterion for clinical decision-making. Findings regarding the CRS subgroup require validation in larger cohorts. Optimizing extracorporeal circuit priming and strengthening peri-procedural monitoring may help improve the safety of TPE.
7.Mortality trend and prediction of chronic respiratory disease in Lianyungang City from 2011 to 2029
ZHONG Wei ; LI Weiwei ; XIANG Lu ; CHAI Lili ; DONG Jianmei ; MA Zhaojun ; QIN Xucheng ; ZHANG Weiwei
Journal of Preventive Medicine 2026;38(2):181-186
Objective:
To analyze the mortality trend of chronic respiratory diseases in Lianyungang City, Jiangsu Province from 2011 to 2024, and predict the mortality from 2025 to 2029, so as to provide the evidence for developing forward-looking prevention and control strategies and targeted intervention measures.
Methods:
Chronic respiratory disease death surveillance data in Lianyungang City from 2011 to 2024 were collected through the Jiangsu Chronic Disease Management Information Platform. The crude mortality was calculated and standardized using the data of the Sixth National Population Census in 2010. Average annual percent change (AAPC) was used to analyze the mortality trends of chronic respiratory diseases by gender, region, and age in Lianyungang City from 2011 to 2024. The GM (1,1) grey model was established using the crude mortality of chronic respiratory diseases from 2011 to 2024 to predict the crude mortality of chronic respiratory diseases from 2025 to 2029.
Results:
From 2011 to 2024, the crude mortality and standardized mortality of chronic respiratory diseases in Lianyungang City were 52.20/105 and 36.57/105, respectively. The crude mortality and standardized mortality were 53.14/105 and 43.79/105 in males, respectively, which were higher than 51.17/105 and 30.14/105 in females (both P<0.05). The crude mortality and standardized mortality were 55.62/105 and 39.85/105 in rural areas, respectively, which were higher than 38.11/105 and 24.15/105 in urban areas (both P<0.05). From 2011 to 2024, the standardized mortality of chronic respiratory diseases showed downward trends in the total population, males, females, urban areas, and rural areas (AAPC=-6.956%, -5.175%, -8.659%, -4.290%, and -7.369%, all P<0.05). The crude mortality of chronic respiratory diseases in the total population showed an upward trend with increasing age (P<0.05), reaching a peak of 1 371.20/105 in the ≥80 years group. The top two causes of chronic respiratory disease deaths were chronic obstructive pulmonary disease and bronchial asthma, with 31 792 cases and 3 254 cases, accounting for 82.40% and 8.43%, respectively. The GM (1,1) grey model prediction results showed that the crude mortality of chronic respiratory diseases in the total population from 2025 to 2029 would be 37.91/105, 36.32/105, 34.80/105, 33.34/105, and 31.95/105, respectively (average relative error=8.76%).
Conclusions
From 2011 to 2024, the mortality of chronic respiratory diseases in Lianyungang City showed a downward trend. The risk of death from chronic respiratory diseases was higher in males, rural areas, and the elderly. It is predicted that the mortality of chronic respiratory diseases will decrease year by year from 2025 to 2029.
8.A Dual-Layer Network Dynamics Modeling and Simulation of Medical Surge Risk Diffusion Based on MATLAB and REPAST
Nan MENG ; Yanping WANG ; Yiran GAO ; Tian YU ; Min WEI ; Wanmeng TENG ; Peng WANG ; Fengqian ZHONG ; Lili JIANG ; Jialin LU ; Ning NING ; Avdeev SERGEY ; Qunhong WU
Chinese Hospital Management 2025;45(11):22-27
Objective To explore the coupling mechanism between medical surge response resources and the spread of secondary risks during public health emergencies,as well as the effectiveness of relevant interventions.Methods Based on complex network theory,a dual-layer network model of medical resources and secondary events was constructed.The interactive feedback between medical resource status and secondary event risk,as well as the effects of network structure,were analyzed through MATLAB simulations,REPAST agent-based modeling,and mean-field analysis.Results Simulation and prediction results show that an increase in first-layer resource-deficient nodes significantly raises the activation rate and transmission speed of secondary events,while the clustering and spread of secondary events in the second layer,in turn,intensify resource depletion,creating a negative feedback loop.Mean-field analysis indicates a nonlinear positive correlation between the adequacy of medical resources and the likelihood of secondary events.Network structure analysis reveals that when the average node degree exceeds 8,resource allocation efficiency improves markedly.Conclusion There exists a dynamic coupling and bidirectional feedback relationship between medical resource status and secondary event risks.Enhancing the flexible allocation and responsiveness of medical resources,improving multi-sectoral collaborative monitoring and coordinated regulation,optimizing network connectivity and coordination mechanisms for resource distribution,and establishing dynamic monitoring and tiered early warning systems are key strategies for strengthening the resilience of healthcare systems and effectively containing the spread of secondary events.
9.Cost analysis of hospital-acquired infections in neurosurgery department patients undergoing brain tumor resection
Peng XU ; Xianming QIU ; Yi XU ; Xuan GUO ; Jingyi LYU ; Weiguang LI ; Lili WANG ; Hongzhen LU
Chinese Journal of Nosocomiology 2025;35(22):3463-3467
OBJECTIVE To investigate the incidence of hospital-associated infections among the neurosurgery de-partment patients undergoing brain tumor resection and analyze the economic cost so as to provide scientific bases for formulating prevention strategies.METHODS Totally 1027 patients who underwent brain tumor resection in neurosurgery department of the First Affiliated Hospital of Shandong First Medical University from Jan.1,2020 to Dec.31,2024 were recruited as the research subjects.The 36 patients who had postoperative hos-pital-associated infections were assigned as the infection group,and 991 patients who did not have hospital-associ-ated infection were assigned as the no infection group.The patients of the infection group and the non-infection group were matched in a 1∶1 ratio by using propensity score matching method(caliper value 0.005).The length of hospital stay and costs of medical items were compared between the infection group and the non-infection group,and the economic burden due to the hospital-associated infections was estimated.RESULTS The incidence of hospital-associated infections was 3.51%among the patients undergoing brain tumor resection,and totally 36 pairs were matched successfully with the propensity score.The hospitalization cost of the infection group was 109,103.81(73,370.21,163,628.37)yuan after the matching,which was increased by 50,087.69 yuan as com-pared with the non-infection group(Z=-5.237,P<0.001);the length of hospital stay was 23.00(17.25,36.00)days,which was prolonged by 8.50 days(Z=-3.764,P<0.001).Among the costs of medical items,the medial costs of western medicine,treatment materials and clinical laboratory tests increased most.CONCLUSIONS The control of the costs of western medicine,treatment materials and clinical laboratory tests is the key to reduce the costs of brain tumor resection patients with hospital-associated infections.It is necessary to carry out the real-time monitoring of the hospital-associated infections and early warning of suspected cases and reduce the incidence of hospital-associated infections so as to reduce the economic costs.
10.Discussion on the Medicinal Part and Clinical Use Method of Amomum Vllosum
Minhui WANG ; Lili WU ; Shuang LU
Journal of Zhejiang Chinese Medical University 2025;49(7):871-877
[Objective]To discuss the medicinal part and clinical use method of Amomum villosum.[Methods]Through searching the Yaozhi database,the prescriptions containing Amomum villosum were sorted out,and the medicinal part and use method of Amomum villosum were preliminarily understood.Checking the records of the processing specifications of each province and the investigation of the use of Amomum villosum in various medical units across the country with the questionnaire star,in order to understand the actual use of Amomum villosum throughout the country;the prescriptions containing Amomum villosum in Chinese Medicine Hospital of Puyang from June 1 to December 31,2023 were sorted out to indicate the situation of Amomum villosum in the practical application.[Results]There are 1 076 prescriptions containing Amomum villosum in the Yaozhi database.Among them 21 prescriptions clearly mention whether they have shells,5 prescriptions use Amomum villosum shells as medicine;1 prescription mention slightly decocting,and 22 prescriptions have descriptions of crushing.In the processing specifications of 23 provinces and municipalities,13 prescriptions record the use of Amomum villosum,13 prescriptions use Amomum villosum rice(unshelled Amomum villosum),and 5 prescriptions use both Amomum villosum and Amomum villosum rice;questionnaire star collects a total of 38 questionnaires,involving 14 provinces and municipalities,and the usage is basically the same as the processing specifications of each province.In the prescriptions containing Amomum villosum in the second half of 2023 in Chinese Medicine Hospital of Puyang,50.5%of the prescriptions are marked with later decocted,and 49.5%of the prescriptions are decocted together.[Conclusion]Medication site of Amomum villosum:Amomum villosum includes Amomum villosum rice and Amomum villosum shell,but there is no clear conclusion on the medicinal part specific application of which part;Amomum villosum should be crushed before use in the clinic;whether it should be added late during decoction should be determined according to whether its components volatile or non-volatile.


Result Analysis
Print
Save
E-mail